Research Article

Prevalence, Clinical Presentation, and Outcome of Tuberculosis in Patients with Chronic Kidney Disease at a Tertiary Care Hospital in Nepal

Table 8

Factors affecting outcomes of TB patients at two months of starting ATT.

ParametersImproved (%)Not improved (%)Mortality (%)Lost to follow-up (%)Total

Duration of symptoms before TB diagnosis
 <2 weeks5 (41.7)2 (16.7)4 (33.3)1 (8.3)12
 ≥2 weeks24 (64.9)2 (5.4)10 (27)1 (2.7)37

CKD stage
 Stage 32 (66.7)0 (0)1 (33.3)0 (0)3
 Stage 43 (42.9)0 (0)4 (57.1)0 (0)7
 Stage 54 (50)0 (0)3 (37.5)1 (12.5)8
 Stage 5D20 (64.5)4 (13)6 (19.3)1 (3.2)31

Duration of MHD
 Less than 6 months11 (68.8)2 (12.5)2 (12.5)1 (6.2)16
 6 months to 1 year6 (75)0 (0)2 (25)0 (0)8
 More than one year3 (43)2 (28.5)2 (28.5)0 (0)7

Session of MHD per week
 One0 (0)1 (100)0 (0)0 (0)1
 Two19 (65.5)3 (10.4)6 (20.7)1 (3.4)29
 Three1 (100)0 (0)0 (0)0 (0)1

History of contact with TB patients
 Yes10 (66.7)0 (0)3 (20)2 (13.3)15
 No19 (55.8)4 (11.8)11 (32.4)0 (0)34

Corticosteroid
 Yes3 (37.5)0 (0)5 (62.5)0 (0)8
 No26 (63.4)4 (9.8)9 (22)2 (4.8)41

Immunosuppressive drugs
 Yes2 (66.7)0 (0)1 (33.3)0 (0)3
 No27 (58.7)4 (8.7)13 (28.3)2 (4.3)46

Diabetes mellitus
 Yes6 (46.2)2 (15.4)4 (30.8)1 (7.6)13
 No23 (63.9)2 (5.6)10 (27.8)1 (2.7)36